Tag Archives: Noel Atkinson

Akumin Inc (AKU.U) Gets a Buy Rating from Clarus

The Technology company, Akumin Inc (AKU.U – Research Report), has received a rating update from a Wall Street analyst today. The company received a Buy rating from Clarus’ analyst Noel Atkinson, with a C$6.50 price target. Atkinson wrote: “We have

Aphria Inc (APHA) Receives a Buy from Clarus

Aphria Inc (APHA – Research Report), the Healthcare company, has received a rating update from a Wall Street analyst today. The company received a Buy rating from Clarus’ analyst Noel Atkinson, with a C$22.75 price target. Atkinson noted: “We had

Clarus Reaffirms Their Buy Rating on CRH Medical (CRH)

Shares of CRH Medical (CRH – Research Report) were revisited by a Wall Street analyst on March 14. Analyst Noel Atkinson from Clarus remains bullish on the stock. Atkinson wrote: “We believe a period of calm for reimbursement rates will

Liberty Health Sciences Inc (LHS) Receives a Buy from Clarus

In a new note to investors today, an analyst has provided a rating update for the Healthcare company, Liberty Health Sciences Inc (LHS – Research Report). Analyst Noel Atkinson from Clarus remains bullish on the stock and has a C$1.75

Clarus Thinks BeWhere Holdings’ Stock is Going to Recover

In a new note to investors today, an analyst has provided a rating update for the Materials sector company, BeWhere Holdings (TSXV: BEW). Analyst Noel Atkinson from Clarus rated BeWhere Holdings (TSXV: BEW) a Buy, setting a C$1 price target.

Clarus Sticks to Its Buy Rating for UrtheCast (UR)

The Materials sector company, UrtheCast (TSX: UR), has received a rating update from a Wall Street analyst on October 19. Clarus’ analyst Noel Atkinson reiterates their Buy rating on the shares, with a C$1 price target. Atkinson said: “We estimate